Karyopharm Therapeutics Inc. Debt Instrument, Convertible, If-converted Value in Excess of Principal
Karyopharm Therapeutics Inc. (KPTI) reported Debt Instrument, Convertible, If-converted Value in Excess of Principal of $0 for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-02.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal · last filed 2020-11-02
- Karyopharm Therapeutics Inc. debt instrument, convertible, if-converted value in excess of principal for the quarter ending 2020-09-30 was $0.00.
- Karyopharm Therapeutics Inc. debt instrument, convertible, if-converted value in excess of principal for the quarter ending 2020-06-30 was $0.00.
- Karyopharm Therapeutics Inc. debt instrument, convertible, if-converted value in excess of principal for the quarter ending 2020-03-31 was $0.00.
- Karyopharm Therapeutics Inc. debt instrument, convertible, if-converted value in excess of principal for the quarter ending 2019-09-30 was $0.00.
- Karyopharm Therapeutics Inc. debt instrument, convertible, if-converted value in excess of principal for fiscal 2018 was $0.00.
| Period end | Debt Instrument, Convertible, If-converted Value in Excess of Principal 3 month | Debt Instrument, Convertible, If-converted Value in Excess of Principal 6 month | Debt Instrument, Convertible, If-converted Value in Excess of Principal 9 month | Debt Instrument, Convertible, If-converted Value in Excess of Principal 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $0.00 derived: sum of 2 quarters · filed 2020-11-02 | $0.00 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $0.00 10-Q · filed 2020-08-04 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-05 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |